
TransMedics Group Investor Relations Material
Latest events

Q2 2025
TransMedics Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TransMedics Group Inc
Access all reports
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. It develops Organ Care System platform that enables the assessment of donor organ viability, the maintenance of donor organ function, and intervention in the organ procurement process for use in lung, heart, kidney and liver transplantations.
Key slides for TransMedics Group Inc


Investor Day 2024
TransMedics Group Inc


Q2 2025
TransMedics Group Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
TMDX
Country
🇺🇸 United States